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Introduction
• Obstructive Sleep Apnea 
(OSA)
• CPAP therapy is the gold 
standard
• OSA significantly promotes 
cardiovascular risk1
• Studies have shown 
associations between long 
term variability of blood 





• CPAP therapy shown to improve predictors of cardiovascular events: 
blood pressure, resting heart rate, sympathetic activation, blood vessel 
stiffness, and mood
• Previous studies showed mixed results of long-term therapy on incidence 
of cardiovascular events3
– Low CPAP adherence (< 4 hrs/night) may not have been 
representative of therapy
– In another study among compliant patients, CPAP reduced the risk of 
adverse CV events by 30%4
• Our project:
– Largest proposed retrospective study (n = 5000)
– Looks at the effect of CPAP usage hours on CVD outcomes




– How does continuous airway pressure (CPAP) therapy 
affect cardiovascular risk factors in patients with 
moderate to severe obstructive sleep apnea (OSA)?
– How does the incidence of cardiovascular events in 
patients with OSA differ between patients who are 
compliant and noncompliant with CPAP therapy?
• Hypothesis
– The incidence of cardiovascular events is decreased in a 
dose dependent fashion in patients with moderate to 
severe OSA who comply with CPAP therapy. 
Approach & Methods
• Study design: Retrospective Medical Chart Review
• Study sample: N = 10 pilot study
– Patients from Jefferson Sleep Center
– With moderate to severe OSA
• Data source and collection
– Full EPIC chart review for inclusion variables
– From 6 months before PSG to now





– Recreational drug use
– Malignancy diagnosis
– Mild OSA
– Upper airway surgeries
– Myopathies, GBS, ALS, MS
• Outcomes
– Major adverse cardiovascular events
– Cardiovascular risk factors
• Blood pressure variability





Sample Size 3 7 10
Mean Age 67.7 65.9 65.8
Female 3 2 5











Mean Std Dev Std Err
CPAP 5 132.04 137.00 -4.85 16.10 7.20
Control 3 122.50 121.33 1.17 38.78 22.39
Variances t value p value







Mean Std Dev Std Err
CPAP 5 76.42 81.80 -4.50 5.00 2.24
Control 3 73.00 68.00 5.00 13.53 7.81
Variances t value p value







Mean Std Dev Std Err
CPAP 5 75.50 74.20 1.3 7.55 3.37
Control 3 83.00 82.50 0.50 2.78 1.61
Variances t value p value
Pooled t-test Equal 0.17 0.87
Conclusions
• Data on cardiovascular events not sufficient
• Control subjects had SBP drop of 1 mmHg vs CPAP subjects 
who increased by 5 mmHg; DBP drop of 5 mmHg vs control 
subjects who increased by 5 mmHg, but not significant: 
likely due to BP meds, sample size
– p = 0.2
• A larger, controlled sample size is necessary to truly test our 
hypothesis: Data collection ongoing
• These findings can be used to inform physicians about the 
importance of CPAP therapy in managing both OSA and 
long-term cardiovascular health and complications
Future Directions
• Complete comprehensive chart review for 
remaining patients such that n = 5000
• Need to better elucidate the potential 
significance of CPAP therapy on BP and HR 
variability
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